--
Technology & Innovation

New diabetes technology coming in 2023

  • Aug-13-2022
  • Facebook
  • Twitter
  • Instagram
  • Pinterest

While 2022 has been a much more exciting year in diabetes technology than the last few, 2023 is poised to be equally as compelling. Pandemic-related bottlenecks in the approval pipeline are clearing up and making way for long-awaited developments for the diabetes community, from pens to pumps to continuous glucose monitors (CGMs).

2022 highlights

In the second half of 2022 and heading into 2023, these items are either recently available or expected to become available later:

  • Insulet Omnipod 5: Formerly known as "Horizon", the Omnipod 5 system is now available for patients living with type 1 diabetes (t1d). It is the first FDA-approved patch pump insulin delivery system with an algorithm for automatic insulin dosing decisions and features machine learning to help the system get to know the patient's needs over time.

  • Senseonics Eversense 180-Day CGM System: The Eversense 180-Day implantable sensor became available in the US in the earlier part of 2022. It requires calibration once daily, down from twice daily with the 90-day implant.

  • Dexcom G7 CGM: Thinner, smaller, and fully disposable, the Dexcom G7 is expected to last for a 14-day sensor session. It will also go from the current two hour warm up period (that the G6 offers) to a 30-minute warm-up period, significantly decreasing the amount of time spent without data. At this point in time, the G7 is expected to become available in the second half of 2022.

  • Abbott Freestyle Libre 3: The Libre 3 will differ from earlier models by not requiring regular scans and providing blood glucose threshold alerts alongside readings every minute. It is reported to be the smallest and thinnest CGM sensor to date. Now that the Libre 3 has been approved by the FDA, it is expected to come to market later in 2022.


What's coming in 2023

When it comes to medical devices, release dates are not guaranteed, but these insulin delivery tools are expected to become available in 2023:

  • Tandem Mobi: Bridging the 2022 limited release of smartphone control for the X2 and this new Tandem model (formerly known as "t:sport"), the Mobi will utilize the ControlIQ algorithm within a compact pump. The pump itself will be able to connect with currently available tubing lengths as well as a 4-inch set, making it similar to the size of a patch pump.

  • Medtronic Minimed 780G: The 780G will be an advanced hybrid closed loop (AHCL) system. It will have remote software updates as well as an adjustable blood glucose target between 100 mg/dl and 120 mg/dl. Data presented at the 2022 ADA Scientific Sessions demonstrates the ability to meet 70% time in range guidelines.

  • Lilly Tempo Smart Pen: The Tempo Pen will be part of the Tempo Personalized Diabetes Management Platform, which is still under development. The system is expected to transmit insulin dosing information between the pen and mobile app, eventually providing personalized insulin dosing decision support. It is expected to be compatible with a variety of user-facing programs and tools.

  • Bigfoot Biomedical Unity System: The Bigfoot Unity Diabetes Management System integrates smart pen caps, the Freestyle Libre 2, a blood glucose meter, and a mobile app to utilize features that have previously been exclusive to pump therapy. The supplies are bundled and delivered on a regular schedule, similar to a subscription model, which saves you a trip to the pharmacy. While the system is currently available in limited markets, a wide release is still pending.


How to access new or upgraded diabetes technology

If you find the idea of these recent and upcoming technologies appealing, you might be wondering how to access them so you can start putting them to work in your diabetes management regimen. The first step is waiting for FDA approval and widespread distribution by the manufacturer. Then, you and your doctor can discuss whether the new technology can help to improve your health and quality of life with diabetes. If it's a good fit for you, your physician can write a prescription, which can then be sent to a pharmacy or durable medical supplier like Edgepark to be filled. Once the pharmacy or supplier verifies your insurance benefits and confirms the order, you'll be on your way to experiencing new diabetes technology.

Would you be prepared to handle a mishap with your diabetes technology? Learn more about how to safely manage an insulin pump malfunction on Edgepark Health Insights.

Diabetes Management Tip